Chemed Pays $6M To Exit Investors' Medicare Fraud Suit
Chemed Corp. has agreed to pay $6 million to settle a putative class action in Ohio federal court accusing it of misleading shareholders about a scheme to defraud Medicare and Medicaid,...To view the full article, register now.
Already a subscriber? Click here to view full article